Brief: Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
11/03/2026 11:02
March 11 (Reuters) - Precision BioSciences Inc DTIL.O: PRECISION BIOSCIENCES RECEIVES U.S. PATENT ALLOWANCES COVERING THE PBGENE-HBV PROGRAM Source text: ID:nBw1p583ka Further company coverage: DTIL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precision Biosciences
See all newsPrecision BioSciences Inc reports results for the quarter ended June 30 - Earnings Summary
Precision BioSciences Q2 net loss widens on warrant liability charge
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Brief: Precision Biosciences - Enters First Amendment To Loan And Security Agreement With Banc Of California - SEC Filing